Clinical Trials Sponsored by Consorzio Oncotech

Total 313 results

Consorzio Oncotech

Recruiting

Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Metastatic Breast Cancer | Locally Advanced Breast Cancer

Italy
Consorzio Oncotech

Completed

Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study (ARIES)

Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer

Italy
Consorzio Oncotech

Active, not recruiting

Atezolizumab Plus CArboplatin Plus Nab-paclitaxel

Metastatic Breast Cancer | Triple Negative Breast Cancer | PD-L1 Gene Mutation

Italy
Consorzio Oncotech

Active, not recruiting

Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Unknown

Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin (LUNG-NEPA)

Chemotherapy-induced Nausea and Vomiting

Italy
Consorzio Oncotech

Completed

NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer (GIM15-NEPA)

Chemotherapy-induced Nausea and Vomiting
Consorzio Oncotech

Unknown

Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments (BIO-META)

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Completed

FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC (GIM9)

Breast Cancer

Italy
Consorzio Oncotech

Active, not recruiting

Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients (GIM 23- POSTER)

Early Breast Cancer

Italy
Consorzio Oncotech

Unknown

Overcoming Endocrine Resistance in Metastatic Breast Cancer (OVER)

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Recruiting

Efficacy of PErioperative PEmbrolizumab Treatment in Patients With Resectable Metastases From Kidney Cancer (PE-PE)

Oligometastatic Renal Cell Carcinoma

Italy
Consorzio Oncotech

Completed

Liquid Biopsy: Intercepting Mutational Trajectories of HER2 (Human Epidermal Growth Factor Receptor 2) Breast Cancer (GIM21 Trial) (GIM21)

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Unknown

CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

Prostate Cancer | Castration-resistant Prostate Cancer

Italy
Consorzio Oncotech
Pfizer

Recruiting

Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients (AxIn)

Metastatic Renal Cell Carcinoma

Italy
Consorzio Oncotech
Roche Pharma AG

Recruiting

Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy

Breast Cancer

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients (GIM11-BERGI)

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer (FEVEX)

Breast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant Neoplasm

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients (FUMANCE)

Metastatic Breast Cancer

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Recruiting

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma (TIDE-A)

Renal Carcinoma Metastatic

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies

Metastatic Breast Cancer

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Observation of Medical Treatments in MBC HER2-negative Patients (AMBRA)

Metastatic Breast Cancer

Italy
Consorzio Oncotech
Quercegen Pharmaceuticals; Clinical Research Technology S.r.l.

Unknown

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial (QUASAR)

Kidney Cancer | Renal Cell Carcinoma

Italy
Fondazione Oncotech

Not yet recruiting

NEOadjuvant Abemaciclib and GIredestrant triaL in Patients With ER-positive, HER2-negative Early Breast Cancer (Neo-AGILE)

Breast Cancer

Italy
Consorzio Futuro in Ricerca

Active, not recruiting

IMR Evaluation in Patients With Coronary Sinus Reducer Implantation (INROAD Study) (INROAD)

Refractory Angina Pectoris

Italy
Consorzio Futuro in Ricerca

Active, not recruiting

Functional Assessment in Elderly MI Patients With Multivessel Disease (FIRE)

Myocardial Infarction

Spain, Italy, Poland
Consorzio Futuro in Ricerca

Completed

Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD (PMC-101-APT)

Asthma | COPD

Italy
Oncotech

Unknown

Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer

Breast Cancer

United States
Consorzio Mario Negri Sud
LifeScan

Completed

Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin (ROSES)

Type 2 Diabetes

Italy
Oscotec Inc.

Completed

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

United States, Greece, Korea, Republic of, Poland, Spain
Oscotec Inc.

Unknown

A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.

Rheumatoid Arthritis

United States, Czechia, Poland, Russian Federation, Ukraine
Consorzio Mario Negri Sud
Artsana SpA

Completed

Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm. (AGO01)

Type 1 Diabetes | Type 2 Diabetes

Italy
Laboratoire Innotech International

Completed

Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs (EDEN)

Chronic Venous Disease of Lower Limbs

France
Consorzio Mario Negri Sud
Sanofi; LifeScan

Unknown

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice (DID3)

Type 1 Diabetes

Italy
Algernon Pharmaceuticals
Novotech (Australia)

Completed

Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease

COVID

Philippines, Australia, United States, Romania
Oscotec Inc.

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

Korea, Republic of
Oscotec Inc.

Completed

A Study of the Absorption, Metabolism, and Excretion of [14C]-SKI-O-703 Following a Single Oral Dose in Healthy Male Subjects

Healthy Volunteers

United States
Consorci Sanitari Integral

Completed

Early Urinary Continence After Radical Prostatectomy: Surgical Procedure and Anatomic Landmarks

Urinary Incontinence | Surgical Procedure, Unspecified | Prostatic Cancer
Consorci Sanitari Integral

Recruiting

Arthroscopic Diagnosis and Treatment of Dorsal Wrist Syndrome in Patients With Synovial Hypertrophy

Synovial Hypertrophy Hand (Diagnosis)

Spain
Consorci Sanitari Integral

Active, not recruiting

Perioperative Management of Preoperative Anemia in Colorectal Cancer

Anemia | Colorectal Cancer

Spain
Consorci Sanitari Integral

Completed

Premixed vs Basal Bolus Insulin Therapy in Older Patients With Type 2 Diabetes

Type 2 Diabetes Treated With Insulin
Oscotec Inc.
PPD

Completed

Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States
Dren Bio
Novotech

Recruiting

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers

Healthy Adult Volunteers

Australia
Dren Bio
Novotech

Recruiting

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Aggressive NK Cell Leukemia | Hepatosplenic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Subcutaneous Panniculitis-Like T-Cell Lymphoma | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | LGLL - Large Granular Lymphocytic Leukemia | Primary Cutaneous T-Cell Lymphoma - Category and other conditions

United States, Australia, France, Spain
Laboratoire Innotech International

Completed

Assessment of the eFficacy, the Onset-of-Action and the Safety of Tot'héma® in Adults With Moderate Iron Deficiency Anaemia (FAST)

Anemia

France
Laboratoire Innotech International

Completed

Open Study of the Efficacy of the Local Treatment With Polygynax of Bacterial and/or Mycotic Vaginitis

Vaginitis
Consorci Sanitari Integral

Not yet recruiting

Two Hypoabsorption Techniques for the Treatment of Type III Obesity (OASIS) (OASIS)

Obesity, Morbid
Consorci Sanitari Integral

Recruiting

Nutritional Support and Telemedicine

Malnutrition

Spain
Consorci Sanitari Integral

Completed

Election of the Optimal Moment of Colecistectomy After Mild Biliary Pancreatitis

Pancreatitis, Acute
Consorci Sanitari Integral

Unknown

Transversus Abdominis Plane Block in the Analgesia of Acute Pancreatitis (TAPA)

Pancreatitis, Acute
Consorci Sanitari Integral

Completed

Radical Laparoscopic Prostatectomy. Enhanced Recovery After Surgery (ERAS) Program

Prostatectomy

3

Subscribe